The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), Dr. Hisham S. Aljadhey, opened a workshop today at the SFDA headquarters in Riyadh, focusing on strengthening partnerships with specialized medical associations. The workshop, held on Monday, was attended by the presidents and members of these associations.
In his opening remarks, Dr. Aljadhey emphasized the significance of the meeting in enhancing the cooperation between the SFDA and medical associations. He stressed the importance of collaborating with healthcare practitioners and building effective communication channels with these associations.
Dr. Aljadhey noted the crucial role healthcare practitioners and medical associations play in supporting the 'Fourth Strategy' of the SFDA, which focuses on product safety. This strategy aims to build trust among healthcare practitioners and improve communication and awareness among the public and medical professionals.
During the workshop, an overview of the pharmaceutical sector in the Kingdom of Saudi Arabia was presented, highlighting several successful collaboration initiatives with medical associations. The importance of continuing such meetings was underscored.
Key topics included creating educational programs on drug safety and effectiveness, disseminating information about medication risks, conducting research studies, engaging with SFDA-published scientific data, and encouraging the reporting of drug side effects.
This workshop is part of the SFDA’s ongoing efforts to strengthen its relationship with medical associations, gather input from specialists, and identify areas of collaboration to achieve shared goals.